Contract 36F79724D0210
Exela Pharma Sciences Llc · Department Of Veterans Affairs · September 23, 2024
Exela Pharma Sciences Llc was awarded a federal contract by Department Of Veterans Affairs on September 23, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 13, 2025. If all options are exercised, the contract could reach $20.30 million.
Contract details
- PIID
- 36F79724D0210
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 23, 2024
- Latest action
- December 13, 2025
Description
2026 PUBLIC LAW UPDATE
Modification timeline
-
December 13, 2025Mod P00013 · Supplemental Agreement For Work Within Scope$0
-
November 12, 2025Mod P00012 · Supplemental Agreement For Work Within ScopePRODUCT DELETION$0
-
September 12, 2025Mod P00010 · Supplemental Agreement For Work Within ScopePERMANENT PRICE REDUCTION$0
-
September 5, 2025Mod P00011 · Other Administrative ActionADMINISTRATIVE MODIFICATION - CORRECTION TO P00008$0
-
July 22, 2025Mod P00009 · Supplemental Agreement For Work Within ScopePRODUCT ADDITION$0
-
September 23, 2024Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79724D0210?
Contract 36F79724D0210 is a federal contract awarded to Exela Pharma Sciences Llc by Department Of Veterans Affairs on September 23, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 36F79724D0210?
Exela Pharma Sciences Llc won contract 36F79724D0210 from Department Of Veterans Affairs.
How much is contract 36F79724D0210 worth?
Contract 36F79724D0210 has obligated $0 to date but carries a potential ceiling of $20.30 million if fully funded and all options are exercised.